| Mr Don R Revis Sr, R PH | |
|
150 Sumter Street Ext, Clinton, SC 29325-7703 | |
| (864) 833-5625 | |
| (864) 833-0503 |
| Full Name | Mr Don R Revis Sr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 150 Sumter Street Ext, Clinton, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043342694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3369 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Don R Revis Sr, R PH 150 Sumter Street Ext, Clinton, SC 29325-7703 Ph: (864) 833-5625 | Mr Don R Revis Sr, R PH 150 Sumter Street Ext, Clinton, SC 29325-7703 Ph: (864) 833-5625 |
News Archive
Lupin Pharmaceuticals has announced that on May 16, 2007 it received tentative approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Ziprasidone Hydrochloride Capsules 20mg, 40mg, 60mg and 80mg.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational second-line treatment in hepatocellular carcinoma (HCC).
When a spouse is cognitively impaired, marital communication is impaired. As Alzheimer's disease (AD) progresses, language problems increase in frequency - such as searching for the right word, repeating the same word, asking the same question over and over, or substituting one word for another.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that it has entered into a research collaboration with Mirna Therapeutics (Austin, TX), to determine the utility of combining RXi's proprietary rxRNA™ technology with Mirna's microRNA mimics as potential therapeutics in oncology. The parties will each contribute technology and resources to the collaboration to generate and evaluate novel microRNA compounds.
› Verified 8 days ago
Jan D Smith, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 216 S Broad St, Clinton, SC 29325 Phone: 864-833-4000 Fax: 864-833-6459 | |
Jennifer Bryson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22725 Highway 76 E, Clinton, SC 29325 Phone: 864-833-9185 | |
Dr. Kayce Shealy, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 307 N Broad St, Clinton, SC 29325 Phone: 864-938-3857 | |
Mr. Gerald Wayne Wilson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22725 Highway 76 E, Clinton, SC 29325 Phone: 864-358-7785 | |
Charles Dean Shively, PH.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 307 N Broad St, Clinton, SC 29325 Phone: 864-938-3933 Fax: 864-938-3903 | |
Dr. Zachary R Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 194 Jacobs Hwy, Clinton, SC 29325 Phone: 864-833-5000 Fax: 864-833-2791 |